Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Олатропіл®"'
Publikováno v:
INTERNATIONAL NEUROLOGICAL JOURNAL; № 7.101 (2018); 49-55
МЕЖДУНАРОДНЫЙ НЕВРОЛОГИЧЕСКИЙ ЖУРНАЛ; № 7.101 (2018); 49-55
МІЖНАРОДНИЙ НЕВРОЛОГІЧНИЙ ЖУРНАЛ; № 7.101 (2018); 49-55
МЕЖДУНАРОДНЫЙ НЕВРОЛОГИЧЕСКИЙ ЖУРНАЛ; № 7.101 (2018); 49-55
МІЖНАРОДНИЙ НЕВРОЛОГІЧНИЙ ЖУРНАЛ; № 7.101 (2018); 49-55
The evolution of drugs in the 21st century was marked by a significant increase in the requirements for their efficacy and safety. At the same time, a rather limited range of drugs, in particular nootropics with truly unique clinical and pharmacologi
Publikováno v:
Family Medicine; № 2 (2018); 33-40
Семейная медицина; № 2 (2018); 33-40
Сімейна медицина; № 2 (2018); 33-40
Семейная медицина; № 2 (2018); 33-40
Сімейна медицина; № 2 (2018); 33-40
The article is devoted to the actual problem of modernity – chronic cerebrovascular pathology. The data on efficacy of therapy with combined nootropic Olatropyl are presented in comparison with piracetam in patients with chronic brain ischaemia due
Publikováno v:
Medicine of Ukraine; № 1(217) (2018); 55-60
Лекарства Украины; № 1(217) (2018); 55-60
Ліки України; № 1(217) (2018); 55-60
Лекарства Украины; № 1(217) (2018); 55-60
Ліки України; № 1(217) (2018); 55-60
The purpose of the study was to evaluate the efficacy of the drug Olatropil (JSC «Olainfarm», Latvia) in the complex treatment of patients with chronic cerebrovascular diseases of high and very high cardiovascular risk (CVR).Materials and methods.
Publikováno v:
Family Medicine; № 3(71) (2017); 104-112
Семейная медицина; № 3(71) (2017); 104-112
Сімейна медицина; № 3(71) (2017); 104-112
Семейная медицина; № 3(71) (2017); 104-112
Сімейна медицина; № 3(71) (2017); 104-112
Цель исследования: оценка влияния фиксированной комбинации ноотропного препарата Олатропил® на нейровегетативные, психоэмоциональны
Publikováno v:
INTERNATIONAL NEUROLOGICAL JOURNAL; № 3.73 (2015); 61-67
МЕЖДУНАРОДНЫЙ НЕВРОЛОГИЧЕСКИЙ ЖУРНАЛ; № 3.73 (2015); 61-67
МІЖНАРОДНИЙ НЕВРОЛОГІЧНИЙ ЖУРНАЛ; № 3.73 (2015); 61-67
МЕЖДУНАРОДНЫЙ НЕВРОЛОГИЧЕСКИЙ ЖУРНАЛ; № 3.73 (2015); 61-67
МІЖНАРОДНИЙ НЕВРОЛОГІЧНИЙ ЖУРНАЛ; № 3.73 (2015); 61-67
The article discusses the treatment of patients with chronic cerebral ischemia stage I on a background of essential hypertension stage І–ІІ. The importance of finding the ways to minimize the number of drugs that must be prescribed to such patie